Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...

Amblest Kanu, a graduate of Medical Laboratory Science, Faculty of Clinical Sciences, Lead City University, Oyo State, tells AYOOLA OLASUPO about some of the challenges he faced as a sickle cell ...

irrespective of hydroxyurea use and sickle cell genotype. SUSTAIN was the basis for FDA approval and European Medicines ...

Thus, people who carry the sickle-cell allele are more likely to recover from malarial infection. In terms of combating malaria, the Ss genotype has an advantage over both the SS genotype ...

A sickle cell gene therapy treatment has allowed a Long Island man to turn a chapter in his life, with doctors declaring him ...

Sickle-cell trait haplotype distribution shows the ... lead to treatments tailored to specific patients based on their genotype, allowing for improved prognosis and quality of life.

Thirty-nine percent of those with verified hemoglobin SS genotype — the most severe type of sickle cell disease — were prescribed disease-modifying therapy. Overall, patients prescribed ...

Since sickle cell disease (SCD) carries an increased risk for ischemic stroke, stroke prevention in this patient population is vital. To this end, the 2014 NHLBI guidelines specify that children with ...

Sebastien Beauzile, 21, has been cured of sickle cell anemia, according to his doctors at Cohen Children’s Medical Center.

irrespective of hydroxyurea use and sickle cell genotype. SUSTAIN was the basis for FDA approval and European Medicines Agency (EMA) approval for crizanlizumab for the prevention of vaso-occlusive ...